A Study on Diagnostic Methodology on Neerkuri Neikuri In Piramiyam/Hiv
Phase 3
- Conditions
- Health Condition 1: null- priyamiyam/Hiv
- Registration Number
- CTRI/2018/04/013029
- Lead Sponsor
- Deebalakshmi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Well diagnosed HIV patient
Exclusion Criteria
Patient who is not willing for neerkuri and neikkuri examination
Severe complicated patient of hiv
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To document the diagnostic patterns of Neikkuri in piramiyam/HIV <br/ ><br>To observe for any significant Neikkuri pattern which may provide a clue in the diagnosis, prognosis or its complicationsTimepoint: To document the diagnostic patterns of Neikkuri in piramiyam/HIV <br/ ><br>To observe for any significant Neikkuri pattern which may provide a clue in the diagnosis, prognosis or its complications
- Secondary Outcome Measures
Name Time Method To observe for any significant Neikkuri pattern which may provide a clue in the diagnosis, prognosis or its complicationsTimepoint: To observe for any significant Neikkuri pattern which may provide a clue in the diagnosis, prognosis or its complications
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms are being explored in the CTRI/2018/04/013029 trial for HIV diagnostics?
How does the CTRI/2018/04/013029 trial's diagnostic approach compare to standard-of-care HIV testing in terms of sensitivity and specificity?
Which biomarkers are evaluated in CTRI/2018/04/013029 to predict treatment response in HIV-infected individuals?
What adverse events are reported with the CTRI/2018/04/013029 diagnostic protocol for HIV management?
Are there alternative diagnostic methods for HIV similar to those in the CTRI/2018/04/013029 observational trial by Deebalakshmi?